Log in
RC

Rubric Capital Management LP

Rubric Capital Management LP · Investor
1Y performance ⓘ
+51%
AUM (13F)
$9.4B
# of Holdings
81
3Y performance ⓘ
+113%
vs S&P 500 ⓘ
+41%
Updated
Mar 31

Rubric Capital Management LP's Rubric Capital Management LP holds 81 U.S.-equity positions worth $9.4B (SEC 13F, Q1 2026). Top positions: Ishares Tr 13.5%, Talen Energy Corporation Common Stock 12.2%, FTAI Aviation Ltd. Common Stock 6.7%. 13F-replication return is +113% over 3 years (+41 pts vs the S&P 500) — a replicated, non-audited figure.

Holdings

Stock% of portfolio SharesValue Latest activityAvg buy price Current priceDate
IWM Ishares Tr 13.5% 5.2M $1.3B NEW (+5.2M) $178.40 $298.18 (+67%) 2026-03-31
TLN Talen Energy Corporation Common Stock 12.2% 3.6M $1.1B $178.24 $438.12 (+146%) 2026-03-31
FTAI FTAI Aviation Ltd. Common Stock 6.7% 2.6M $631M ▼ 30% (−1.1M) $111.03 $272.05 (+145%) 2026-03-31
GLNG Golar LNG Ltd 5.3% 9.2M $497M $21.60 $50.75 (+135%) 2026-03-31
TEVA Teva Pharmaceutical Inds Ltd 4.9% 15.2M $459M ▼ 29% (−6.1M) $8.85 $32.20 (+264%) 2026-03-31
VTRS Viatris Inc. Common Stock 4.8% 33.5M $453M ▲ 31% (+8.0M) $9.98 $15.38 (+54%) 2026-03-31
TAC TransAlta Corporation 2.5% 17.8M $233M $8.75 $13.85 (+58%) 2026-03-31
BGC BGC Group, Inc. Class A Common Stock 2.4% 23.3M $228M ▲ 11% (+2.3M) $5.28 $12.08 (+129%) 2026-03-31
VST Vistra Corp. 2.4% 1.5M $225M ▼ 25% (−500K) $24.00 $167.26 (+597%) 2026-03-31
CEG Constellation Energy Corporation Common Stock 2.1% 715K $200M ▲ 6.7% (+45K) $322.76 $275.53 (−15%) 2026-03-31
ARQT Arcutis Biotherapeutics, Inc. Common Stock 2.1% 8.3M $195M $11.00 $26.66 (+142%) 2026-03-31
MCY Mercury General Corp. 2.0% 2.2M $190M ▲ 4.9% (+100K) $55.90 $103.15 (+85%) 2026-03-31
KNSA Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares 1.9% 3.8M $181M ▲ 13% (+421K) $18.67 $57.13 (+206%) 2026-03-31
ZYME Zymeworks Inc. 1.9% 7.0M $175M ▲ 22% (+1.2M) $9.04 $23.26 (+157%) 2026-03-31
AKAM Akamai Technologies Inc 1.6% 1.3M $149M ▲ 8.3% (+100K) $87.25 $120.74 (+38%) 2026-03-31
LBTYA Liberty Global Ltd. Class A Common Shares 1.5% 11.8M $142M ▲ 17% (+1.7M) $17.77 $11.03 (−38%) 2026-03-31
ROIV Roivant Sciences Ltd. Common Shares 1.5% 5.0M $138M ▼ 44% (−4.0M) $7.38 $31.25 (+323%) 2026-03-31
AMRX Amneal Pharmaceuticals, Inc. Class A Common Stock 1.4% 11.0M $137M ▼ 11% (−1.3M) $3.10 $16.11 (+420%) 2026-03-31
LILAK Liberty Latin America Ltd. Class C Common Stock 1.4% 15.4M $136M ▲ 44% (+4.7M) $8.44 $5.30 (−37%) 2026-03-31
DK Delek US Holdings, Inc. 1.3% 2.7M $121M $18.75 $42.88 (+129%) 2026-03-31
CMPR Cimpress PLC Ordinary Shares (Ireland) 1.3% 1.6M $119M ▲ 6.8% (+104K) $43.82 $86.66 (+98%) 2026-03-31
ECVT Ecovyst Inc. 1.2% 9.1M $117M ▼ 13% (−1.4M) $8.23 $12.89 (+57%) 2026-03-31
LBTYK Liberty Global Ltd. Class C Common Shares 1.1% 9.3M $109M ▲ 51% (+3.1M) $18.64 $10.60 (−43%) 2026-03-31
ADEA Adeia Inc. Common Stock 1.1% 4.3M $103M $8.86 $31.81 (+259%) 2026-03-31
EPC Edgewell Personal Care Company 0.9% 4.0M $85M ▲ 297% (+3.0M) $17.05 $22.72 (+33%) 2026-03-31
ZM Zoom Communications, Inc. Class A Common Stock 0.8% 1.0M $80M NEW (+1.0M) $80.39 $84.34 (+5%) 2026-03-31
TDS Telephone and Data Systems Inc. 0.8% 1.9M $78M $39.24 $38.94 (−1%) 2026-03-31
GIL Gildan Activewear Inc. 0.8% 1.4M $78M ▲ 444% (+1.1M) $57.80 $52.09 (−10%) 2026-03-31
IART Integra LifeSciences Holdings 0.8% 7.8M $73M $18.17 $17.60 (−3%) 2026-03-31
SDGR Schrodinger, Inc. Common Stock 0.7% 6.0M $68M ▲ 44% (+1.8M) $26.33 $15.23 (−42%) 2026-03-31
SPRY ARS Pharmaceuticals, Inc. Common Stock 0.7% 8.0M $64M ▲ 29% (+1.8M) $6.51 $9.98 (+53%) 2026-03-31
GEO The GEO Group, Inc. 0.7% 3.7M $63M ▲ 7.3% (+256K) $29.21 $29.67 (+2%) 2026-03-31
SSYS Stratasys Inc (ISRAEL) 0.7% 8.0M $62M ▲ 9.0% (+660K) $13.61 $8.63 (−37%) 2026-03-31
ANDE Andersons Inc/The 0.7% 856K $61M ▼ 15% (−150K) $53.17 $70.86 (+33%) 2026-03-31
MGTX MeiraGTx Holdings plc Ordinary Shares 0.6% 7.0M $61M ▲ 13% (+825K) $6.78 $11.48 (+69%) 2026-03-31
ENOV Enovis Corporation 0.6% 2.5M $56M $30.34 $21.30 (−30%) 2026-03-31
OPK Opko Health Inc. 0.6% 47.8M $54M $1.20 $1.43 (+19%) 2026-03-31
QDEL QuidelOrtho Corporation Common Stock 0.6% 3.3M $54M ▼ 12% (−471K) $73.04 $12.37 (−83%) 2026-03-31
PRMB Primo Brands Corporation 0.6% 2.8M $52M ▼ 23% (−846K) $16.35 $23.53 (+44%) 2026-03-31
NWL Newell Brands Inc. 0.6% 15.3M $52M ▲ 17% (+2.3M) $5.24 $5.03 (−4%) 2026-03-31
AMCR Amcor plc Ordinary Shares 0.5% 1.3M $50M NEW (+1.3M) $39.75 $40.68 (+2%) 2026-03-31
RNW ReNew Energy Global plc Class A Ordinary Shares 0.5% 11.0M $50M $5.62 $6.43 (+14%) 2026-03-31
PRTA Prothena Corporation plc Ordinary Shares 0.5% 5.0M $49M ▲ 36% (+1.3M) $9.76 $9.15 (−6%) 2026-03-31
PTGX Protagonist Therapeutics, Inc 0.5% 428K $45M NEW (+428K) $28.93 $115.03 (+298%) 2026-03-31
TRVI Trevi Therapeutics, Inc. Common Stock 0.5% 3.7M $44M ▼ 1.4% (−54K) $1.85 $17.71 (+857%) 2026-03-31
OFIX Orthofix Medical Inc. Common Stock (DE) 0.5% 3.7M $43M $16.75 $8.95 (−47%) 2026-03-31
COLL Collegium Pharmaceutical, Inc. Common Stock 0.5% 1.3M $42M ▼ 14% (−217K) $23.99 $33.45 (+39%) 2026-03-31
CXW CoreCivic, Inc. 0.4% 2.1M $39M ▲ 5.0% (+98K) $20.29 $29.65 (+46%) 2026-03-31
NRIX Nurix Therapeutics, Inc. Common stock 0.4% 2.5M $38M $18.97 $18.65 (−2%) 2026-03-31
DRVN Driven Brands Holdings Inc. Common Stock 0.4% 3.0M $38M NEW (+3.0M) $12.61 $12.27 (−3%) 2026-03-31

Showing top 50 of 81 holdings by value.

Related
IWM stockTLN stockFTAI stockGLNG stockAll hedge funds
FAQ

What are Rubric Capital Management LP's largest holdings?

As of the latest 13F: Ishares Tr 13.5%, Talen Energy Corporation Common Stock 12.2%, FTAI Aviation Ltd. Common Stock 6.7%, Golar LNG Ltd 5.3%, Teva Pharmaceutical Inds Ltd 4.9%.

How big is Rubric Capital Management LP's 13F portfolio?

$9.4B across 81 disclosed U.S.-equity positions.

What is Rubric Capital Management LP's 3-year performance?

+113% (13F-replication, price return), +41 pts vs the S&P 500. Not an audited fund return.

Where does this data come from?

U.S. SEC Form 13F-HR institutional holdings filings.

Sourced from SEC Form 13F-HR filings · Not investment advice
SEC EDGAR 13F
Data as of 2026-03-31 · Methodology
13F-replication (price return, filing-date based) — not an audited fund return.
Published by WealthFile · Not investment advice.

Latest activity = change vs. the prior 13F. Avg buy price = est. entry over the trailing 3 years (gain = vs. latest price). Returns are 13F-replication, not audited fund returns. Sourced from SEC 13F filings.